Brian M Hauge

Title: Brian M Hauge: Innovator in Protein Production and Delivery

Introduction

Brian M Hauge is a notable inventor based in Beverly, MA (US), recognized for his contributions to the field of biotechnology. He holds a patent that focuses on innovative methods for protein production and delivery, which have significant implications for therapeutic applications.

Latest Patents

Hauge's patent, titled "Protein production and delivery," relates to novel human DNA sequences, targeting constructs, and methods for producing genes encoding thrombopoietin, DNase I, and β-interferon through homologous recombination. The invention includes targeting constructs that comprise a targeting sequence, a regulatory sequence, an exon, and a splice-donor site. These constructs can undergo homologous recombination with endogenous cellular sequences to generate a novel gene. The resulting homologously recombinant cells are maintained under conditions that allow for the transcription of the novel gene and translation of the mRNA produced, leading to the production of thrombopoietin, DNase I, or β-interferon. Furthermore, the invention outlines methods for producing pharmaceutically useful preparations containing these proteins and gene therapy methods involving the administration of homologously recombinant cells to patients for therapeutic purposes.

Career Highlights

Brian M Hauge has made significant strides in his career, particularly through his work at Transkaryotic Therapies, Inc. His innovative approach to protein production has positioned him as a key figure in the biotechnology sector.

Collaborations

Hauge has collaborated with notable colleagues, including Douglas A Treco and Michael W Heartlein, contributing to advancements in the field of gene therapy and protein production.

Conclusion

Brian M Hauge's work in protein production and delivery exemplifies the innovative spirit of modern biotechnology. His contributions have the potential to impact therapeutic practices significantly.